Catalyst Wire Dossier Catalyst Wire Dossier

Evenity

romosozumab · Amgen
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for Evenity, covering 2018-12-12 to 2026-07-09. Get the full timeline:

Most recent: EMA Authorised: Evenity (romosozumab) — UCB Pharma S.A.

See pricing